Valuation: Shandong Linuo Pharmaceutical Packaging Co., Ltd.

Market Cap 8.61B 1.28B 1.11B 1.03B 948M 1.79B 122B 1.82B 12.17B 4.78B 60.75B 4.79B 4.69B 201B P/E 2026 *
85.1x
P/E 2027 * 65.1x
Enterprise Value 8.61B 1.28B 1.11B 1.03B 948M 1.79B 122B 1.82B 12.17B 4.78B 60.75B 4.79B 4.69B 201B EV / Sales 2026 *
7.9x
EV / Sales 2027 * 6.96x
Free-Float
67.87%
Yield 2026 *
-
Yield 2027 * -
06-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2025, Payable on 9 June 2026 CI
04-22 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-21 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announces Annual dividend, payable on June 09, 2026 CI
04-20 Shandong Linuo Pharmaceutical Packaging Co., Ltd. announced that it expects to receive CNY 300 million in funding CI
04-06 Nuode Fund Management Co., Ltd., Caitong Fund Management Co., Ltd., Jinxiu Zhonghe Investment Management Co., Ltd. and Allianz Asset Management Co., Ltd acquired 2.99% stake in Shandong Linuo Pharmaceutical Packaging Co., Ltd. from Linuo Investment Holding Group Co., Ltd. for approximately CNY 130 million. CI
03-31 Shandong Linuo Pharmaceutical Packaging's controlling shareholder plans to sell 3.0% stake RE
12-15 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
12-14 Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback announced on February 7, 2025, has closed with 4,557,700 shares, representing 1.99% for CNY 81.11 million. CI
11-03 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Approves Board Elections CI
25-10-27 Shandong Linuo Pharmaceutical Packaging Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-10-09 Tranche Update on Shandong Linuo Pharmaceutical Packaging Co., Ltd.'s Equity Buyback Plan announced on February 7, 2025. CI
25-09-28 Shandong Linuo Pharmaceutical Packaging Co., Ltd. completed the acquisition of 30% stake in Suzhou Chuangyang New Materials Technology Co., Ltd. from Shanghai Miaoxiang Enterprise Management Consulting Co., Ltd., Taicang Chuangyang Qiyun Enterprise Management Partnership Enterprise (Limited Partnership), Shanghai Shizhi Enterprise Management Co., Ltd. and Shanghai Jiuban Intelligent Technology Co., Ltd. CI
25-09-09 Shandong Linuo Pharmaceutical Packaging's shareholder to unload shares RE
1 day+4.97%
1 week-5.06%
1 month-50.39%
3 months+23.61%
6 months+72.33%
Current year+88.58%
1 week 30.71
Extreme 30.71
38.56
1 month 29
Extreme 29
62.25
Current year 15.07
Extreme 15.07
76.3
1 year 15.07
Extreme 15.07
76.3
3 years 10.78
Extreme 10.78
76.3
5 years 10.78
Extreme 10.78
76.3
10 years 10.78
Extreme 10.78
76.3
Manager TitleAgeSince
Chief Executive Officer 46 2024-04-14
Director of Finance/CFO 45 2022-11-28
Investor Relations Contact - -
Director TitleAgeSince
Chairman 51 2025-10-30
Chairman 47 2023-12-31
Director/Board Member 54 2015-04-05
Change 5-day change 1-year change 3-year change Capi.($)
+4.97%-5.06%+51.55%+129.69% 1.27B
-2.34%+1.86%-1.63%+10.47% 3.55B
-0.60%-2.36%-35.57%-54.97% 2.61B
-0.30%+7.37%-12.23%-23.29% 1.96B
-2.72%-21.26%-44.27%-68.12% 1.1B
-2.11%+5.83%-5.34%-54.63% 755M
+3.91%+2.80%+81.57%+62.44% 617M
+4.15%-2.50%+3.15%+18.70% 550M
-1.05%+3.50%-37.14%-56.85% 464M
-1.29%-2.66%+108.26%+116.46% 368M
Average +0.26%-2.90%+10.83%+7.99% 1.32B
Weighted average by Cap. -0.37%-2.24%-2.64%-2.85%

Financials

2026 *2027 *
Net sales 1.09B 162M 140M 131M 120M 227M 15.42B 230M 1.54B 605M 7.69B 607M 594M 25.44B 1.24B 184M 159M 148M 136M 258M 17.51B 261M 1.75B 687M 8.73B 689M 674M 28.89B
Net income 103M 15.27M 13.27M 12.35M 11.34M 21.44M 1.46B 21.75M 146M 57.16M 727M 57.35M 56.09M 2.4B 137M 20.31M 17.64M 16.42M 15.09M 28.51M 1.94B 28.93M 194M 76.02M 966M 76.28M 74.6M 3.2B
Net Debt - -
Logo Shandong Linuo Pharmaceutical Packaging Co., Ltd.
Shandong Linuo Pharmaceutical Packaging Co Ltd, formerly Shandong Linuo Technical Glass Co Ltd, is a China-based company specialized in the research, development, production and sales of borosilicate special glass. The Company's main products include medium borosilicate pharmaceutical glass and high borosilicate heat-resistant glass series products. Pharmaceutical glass products include low borosilicate pharmaceutical glass series and medium borosilicate pharmaceutical glass series, which are mainly used in medical packaging fields such as blood products, biopharmaceuticals, new drugs and special drugs, vaccines, etc. High borosilicate heat-resistant glass products include heat-resistant glassware, glass trays for microwave ovens, glass lenses, electric light source glass shells and electric light source glass tubes, and others, which are mainly used in residential life fields including dining utensils, kitchen utensils, lighting fixtures, and others.
Employees
1,403
Date Price Change Volume
26-07-31 CN¥33.19 +4.97% 21,714,691
26-07-30 CN¥31.62 -6.84% 16,759,950
26-07-29 CN¥33.94 -4.53% 14,829,603
26-07-28 CN¥35.55 -7.47% 14,256,344
26-07-27 CN¥38.42 +9.90% 15,873,647

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301188 Stock